Virios Therapeutics

+$0.06 (+1.49%) As of 6:15 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIRI and other ETFs, options, and stocks.

About VIRI

Virios Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1 a novel, proprietary, fixed dose combination of famciclovir and celecoxib.

CEO
Greg Duncan
Employees
5
Headquarters
Alpharetta, Georgia
Founded
2012

VIRI Key Statistics

Market cap
34.15M
Price-Earnings ratio
—
Dividend yield
—
Average volume
22.34K
High today
$4.09
Low today
$3.70
Open price
$4.09
Volume
4.05K
52 Week high
$7.45
52 Week low
$3.30

VIRI Earnings

-$1.25
-$0.83
-$0.42
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.53 per share
Actual
-$0.48 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure